Rovida Advisors’s Eli Lilly LLY Stock Holding History

Rovida Advisors’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-219,500	Closed	-$60.6M	–	37
2021 Q4	$60.6M	Hold	219,500	–	–	2.72%	12
2021 Q3	$50.7M	Hold	219,500	–	–	2.15%	19
2021 Q2	$50.4M	Hold	219,500	–	–	2.18%	16
2021 Q1	$41M	Hold	219,500	–	–	1.92%	18
2020 Q4	$37M	Hold	219,500	–	–	2.17%	16
2020 Q3	$32.3M	Hold	219,500	–	–	2.24%	21
2020 Q2	$36M	Buy	+219,500	New	+$33.7M	3.47%	9
2020 Q1	–	Sell	-252,600	Closed	-$33.2M	–	44
2019 Q4	$33.2M	Hold	252,600	–	–	1.76%	20
2019 Q3	$28.2M	Sell	252,600 -43,700	-15%	-$4.87M	1.67%	20
2019 Q2	$32.8M	Hold	296,300	–	–	1.93%	21
2019 Q1	$38.4M	Hold	296,300	–	–	2.61%	14
2018 Q4	$34.3M	Hold	296,300	–	–	2.84%	14
2018 Q3	$31.8M	Hold	296,300	–	–	2.32%	17
2018 Q2	$25.3M	Hold	296,300	–	–	2.08%	18
2018 Q1	$22.9M	Hold	296,300	–	–	2.15%	18
2017 Q4	$25M	Hold	296,300	–	–	2.63%	16
2017 Q3	$25.3M	Hold	296,300	–	–	2.68%	18
2017 Q2	$24.4M	Hold	296,300	–	–	3.36%	14
2017 Q1	$24.9M	Hold	296,300	–	–	4.25%	11
2016 Q4	$21.8M	Buy	+296,300	New	+$22.1M	4.85%	7

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Rovida Advisors's LLY Position: Q1 2022 in Review

Rovida Advisors sold out of Eli Lilly (LLY) in Q1 2022, closing a stake of 219,500 shares — an estimated $60.6M sold.

Rovida Advisors first reported a position in LLY in Q4 2016 and held it in 20 quarters. The position peaked at $60.6M in Q4 2021. 2,345 funds tracked by Wall St. Rank hold LLY as of Q1 2022.

Rovida Advisors reported no remaining Eli Lilly position as of Q1 2022 after selling out during the quarter.
Rovida Advisors sold 219,500 Eli Lilly shares in Q1 2022, an estimated $60.6M.
Rovida Advisors first reported a position in Eli Lilly in Q4 2016 and held it in 20 quarters.
Rovida Advisors's Eli Lilly position peaked at $60.6M in Q4 2021.
2,345 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2022.

Based on Rovida Advisors's 13F filing for Q1 2022, filed 10 May 2022.